Masco (MAS)
NYSEIndustrialsConstruction MaterialsSnapshot 2026-09-14
$69.41+1.30%
Close 2026-09-14 · 1-day change
NYSEIndustrialsConstruction MaterialsSnapshot 2026-09-14
Research Workspace
Put MAS beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Building Products is in recovery. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Achieve at least 3% revenue growth annually: rev -3.0% vs 3.0%.
View ThesisRevenue is contracting — down about 1% over the past year.
View GrowthRanks among the strongest in its industry on quality — around the top 12%.
View QualityManagement screens strong on capital allocation, margins, the balance sheet.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskMasco's growth bets amid soft housing must continue to justify its current price. Revenue fell 3% year over year, but the latest earnings beat showed strong performance. Masco trades at 15× P/E versus a peer median of 18×. This suggests the price reflects less growth than expected. A specific risk is the potential for a guidance cut, which could damage credibility. Peer multiples imply a price about 44% above where it trades. Our read is provisional.
Trailing returns as of 2026-09-14. MAS is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 22 analysts currently covering MAS (as of Sep 2026).
Based on 5 Wall Street analysts offering 12-month price targets for MAS in the last 4 months.
Continue this research
Compare MAS with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MAS Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Building Products — fair value, gap to price, and forward P/E.
Compare the value case
Put MAS next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Maintain and raise adjusted EPS guidance for 2026
Strong volume growth supports adjusted EPS guidance for 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-14. EPS is implied from price ÷ P/E. Not investment advice.
Current $69.41
The last 12 months of price, then the range of analyst 12-month targets from today’s $69.41.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Maintain and raise adjusted EPS guidance for 2026
Strong volume growth supports adjusted EPS guidance for 2026.
Advances: Manage leadership transitions effectively
New leadership role supports operational excellence and innovation.
Advances: Maintain and raise adjusted EPS guidance for 2026
Growth bets align with maintaining EPS guidance.
Threatens: Operational excellence and margin expansion
Revenue misses but profitability benefits from tariff refunds.
Advances: Maintain and raise adjusted EPS guidance for 2026
Masco raised 2026 EPS outlook, confirming growth objective.
Threatens: Maintain EPS guidance
Sales miss expectations, putting EPS guidance at risk.
Sales below estimates may hinder EPS growth guidance.